You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ovarian cancer (BRCA1/2 mutation)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endocrine Disruptors and Life STILe in Breast Cancer Development

Recruiting
  • Breast Cancer
  • +5 more
    • Roma, Italy
      Alessandra Fabi
    Feb 25, 2023

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

    Active, not recruiting
    Has Results
    • BRCA1 Gene Mutation
    • +5 more
    • Durvalumab
    • +3 more
    • Buffalo, New York
    • +1 more
    Jan 20, 2023

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

    Not yet recruiting
    • BRCA Mutation
    • +2 more
    • Germinal BRCA
    • (no location specified)
    Mar 3, 2023

    Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

    Enrolling by invitation
    • Breast Cancer
    • +7 more
    • Dnipro, Ukraine
    • +1 more
    Jun 17, 2023

    Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)

    Active, not recruiting
    • Hereditary Breast and Ovarian Cancer
    • Structured exercise training plus mediterranean diet
    • Cologne, Germany
    • +2 more
    Oct 25, 2022

    Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

    Recruiting
    • Hereditary Breast and Ovarian Cancer
      • Barcelona, Spain
        Hospital de la Santa Creu i Sant Pau
      Jun 3, 2022

      Breast & Ovarian Cancer Risk Detection

      Recruiting
      • Adnexal Mass
      • +3 more
      • OVA360
      • Austin, Texas
        Silvana Franco
      Jul 20, 2022

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer Trial in Netherlands (Salpingectomy with delayed oophorectomy,

      Active, not recruiting
      • BRCA1 Gene Mutation
      • +2 more
      • Salpingectomy with delayed oophorectomy
      • Risk-reducing salpingo-oophorectomy
      • Maastricht, Limburg, Netherlands
      • +12 more
      May 17, 2022

      HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

      Completed
      • Epithelial Ovarian Cancer
      • +6 more
      • Evaluation of homologous recombination deficiency score
      • Beijing, Beijing, China
        Lei Li
      Mar 26, 2022

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

      Recruiting
      • BRCA1 Gene Mutation
      • +19 more
      • Laboratory Biomarker Analysis
      • Pembrolizumab
      • New Brunswick, New Jersey
      • +1 more
      Nov 16, 2022

      MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion

      Active, not recruiting
      • Screening Breast MRI in Patients Who Are BRCA Mutation Carriers
      • MRI
      • Optional Screening Questionnaire
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Apr 19, 2022

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

      Active, not recruiting
      • BRCA1 Gene Mutation
      • +9 more
      • Laboratory Biomarker Analysis
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Sep 16, 2022

      Investigate Adaptation and Evolution of Ovarian High-grade

      Recruiting
      • Ovarian Cancer
      • +6 more
        • Bristol, United Kingdom
        • +10 more
        Sep 8, 2022

        Ovarian Carcinoma Trial in Israel, United States (Denosumab, Salpingo-Oophorectomy)

        Terminated
        Has Results
        • Ovarian Carcinoma
        • Denosumab
        • Salpingo-Oophorectomy
        • Boston, Massachusetts
        • +5 more
        May 23, 2022

        Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

        Recruiting
        • Deleterious BRCA1 Gene Mutation
        • +10 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 23, 2022

        Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

        Active, not recruiting
        • Advanced Malignant Neoplasm
        • +7 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 21, 2022

        Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

        Active, not recruiting
        • Deleterious BARD1 Gene Mutation
        • +13 more
        • Laboratory Biomarker Analysis
        • +4 more
        • Chicago, Illinois
        • +8 more
        Feb 25, 2022

        BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic

        Recruiting
        • BRCA-Mutated Ovarian Carcinoma
        • +30 more
        • Houston, Texas
          M D Anderson Cancer Center
        May 27, 2022

        Hereditary Breast and Ovarian Cancer Trial in Germany (Structured exercise training plus mediterranean diet)

        Recruiting
        • Hereditary Breast and Ovarian Cancer
        • Structured exercise training plus mediterranean diet
        • Berlin, Germany
        • +18 more
        Oct 25, 2022

        BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation Trial in Netherlands (Risk-reducing salpingectomy with delayed

        Recruiting
        • BRCA1 Gene Mutation
        • +5 more
        • Risk-reducing salpingectomy with delayed oophorectomy
        • Risk-reducing salpingo-oophorectomy
        • Tilburg, Brabant, Netherlands
        • +13 more
        Nov 1, 2022

        Ovarian Cancer, Breast Cancer Trial in India (Olaparib)

        Completed
        • Ovarian Cancer
        • Breast Cancer
        • Ahmedabad, India
        • +15 more
        Oct 28, 2022

        Cascade Testing in Families With Newly Diagnosed Hereditary

        Recruiting
        • BRCA-Mutated Ovarian Carcinoma
        • +7 more
        • CASCADE genetic screening
        • New York, New York
          NYU Langone Health
        Apr 30, 2021

        InheriteD brEast caNcer iTalian regIsTrY A

        Recruiting
        • Breast Cancer
          • Aviano, Pordenone, Italy
          • +11 more
          Apr 26, 2023